"Medication is neither a magic fix nor a dangerous last resort. It is a clinical tool — effective for many, not for all, best used as part of a broader approach to support."
This guide is not medical advice. Decisions about ADHD medication for your child should always be made in consultation with a qualified clinician — your child's paediatrician, psychiatrist, or prescribing GP. This guide provides accurate background information to help you engage in that conversation from an informed position.
What the evidence says about medication
ADHD medication is among the most thoroughly researched treatments in all of child psychiatry. Meta-analyses covering thousands of participants consistently show that stimulant medications — methylphenidate and amphetamine-based compounds — produce meaningful improvements in attention, impulse control, and academic performance for the majority of children with ADHD (Cortese et al., 2018, Lancet Psychiatry). Non-stimulant options (atomoxetine, guanfacine) have a more modest effect size but are effective alternatives where stimulants are not tolerated or suitable.
The evidence is also clear that medication alone is not sufficient. Medication optimises the neurological substrate — it can make the executive function system more available — but it does not teach the skills that were missed during development. Behavioural support, emotional regulation work, school accommodations, and parenting strategies remain important regardless of medication status.
Types of ADHD medication
The most commonly prescribed ADHD medication in the UK. Works by increasing dopamine and norepinephrine availability in the prefrontal cortex. Available in short-acting (4–6 hours) and long-acting (8–12 hours) formulations. Typically the first medication tried. Effective in approximately 70–80% of children.
A prodrug that is converted to dexamphetamine in the body — providing a longer-acting, smoother profile than some methylphenidate formulations. Licensed in the UK for children aged 6+ when methylphenidate is not effective or tolerated. Often described as having a more gradual onset and offset.
A selective norepinephrine reuptake inhibitor — not a stimulant. Takes 4–6 weeks to reach full effect. Useful when stimulants are not tolerated, when anxiety is a significant co-occurring concern, or when there are specific reasons to avoid controlled substances. Effect size is modest but meaningful for a significant proportion.
An alpha-2A adrenoceptor agonist that improves prefrontal cortical functioning and reduces impulsivity. Used as monotherapy or as an add-on. Can also help with sleep difficulties, which are common in ADHD.
How titration works
Medication is not simply prescribed and left. It is titrated — started at the lowest effective dose and gradually adjusted based on response and tolerability. This process typically takes several weeks to months. During this period, close monitoring is important: regular check-ins with the prescribing clinician, feedback from school, and parent observation of both benefits and side effects.
It is important to know that the first medication tried is not always the best one for a particular child. If one medication does not produce a good response or produces intolerable side effects, others can be tried. The process requires patience, but for most families, an effective medication match is ultimately found.
Common concerns — answered honestly
Medication should not change personality — it should reduce the interference that ADHD creates, allowing more of who your child actually is to come through. If medication makes a child appear flat, emotionally blunted, or unlike themselves, this is a signal to discuss with the prescriber. The dose may be too high, or the formulation may not be the right fit.
ADHD medication prescribed and monitored appropriately is not associated with dependence in children. Research actually shows that effective treatment of ADHD in childhood reduces the risk of later substance misuse — not the other way around (Humphreys et al., 2013).
Stimulant medication can slow the rate of height gain during treatment in some children. The effect is typically modest and most studies show catch-up growth. Growth should be monitored regularly during treatment — this is standard clinical practice and should happen as part of medication review appointments.
This is a clinical question with no universal answer. Some families use "medication holidays" on weekends when school demands are absent and appetite and sleep are the priority. Others find that the emotional regulation and family functioning benefits make consistent dosing preferable. Discuss this specifically with your prescriber.
Medication is not compulsory. Many children receive substantial benefit from non-medication approaches alone — particularly behavioural parent training, school support, and emotional regulation work. The decision to medicate is yours and your child's, made in partnership with a clinician. There is no single right answer.
Medication and non-medication approaches work best together
The evidence consistently supports a multimodal approach — combining medication (where used) with skills-based interventions, school support, and family strategies. Medication improves the brain's availability for learning; the learning still needs to happen. Emotional regulation skills, executive function strategies, and positive relational experiences all build capacity that medication alone cannot provide.